Key Takeaways
- Shares of Aehr Test Systems surged more than 13% on Thursday following the announcement of a production equipment order for its FOX-XP wafer-level burn-in technology.
- The order represents the company’s third FOX-XP contract secured in 2026, after deals worth $14 million in February and another in March.
- The purchase comes from Aehr’s primary silicon photonics client, which has already deployed and activated an initial system in production.
- The FOX-XP platform enables simultaneous testing of up to nine 300mm wafers with complete automation and zero manual intervention.
- With fiscal Q4 and full-year 2026 results scheduled for July 14, the announcement provides additional upward momentum.
Shares of Aehr Test Systems (AEHR) advanced more than 13% during Thursday’s session after the semiconductor testing equipment manufacturer disclosed a new production equipment contract from its primary silicon photonics client. By midday trading, the stock maintained gains of approximately 11.75%.
The contract covers a fully automated FOX-XP wafer-level burn-in (WLBI) platform, integrated with the FOX WaferPak AutoAligner technology. This combined configuration enables simultaneous testing of up to nine 300mm wafers without requiring any manual intervention.
The client is deploying this equipment to facilitate large-scale manufacturing of silicon photonics components designed for AI optical interconnect applications and hyperscale data center operations.
This represents a repeat purchase from an existing customer. The same client previously received its initial FOX-XP production platform during Aehr’s fiscal 2026, which has been successfully commissioned and is currently operational.
Chief Executive Gayn Erickson characterized the development as “another important milestone” in the ongoing partnership with this customer. He expressed satisfaction at “receiving this additional follow-on production order early in our new fiscal year.”
The announcement also confirms the third FOX-XP WLBI contract Aehr has secured during 2026. The initial order arrived in February with a $14 million valuation, followed by a subsequent contract in March.
Order Volume Exceeds Projections
This past April, Aehr disclosed that it secured over $92 million in orders throughout the latter half of fiscal 2026. This performance significantly exceeded the company’s earlier guidance range of $60 million to $80 million.
Market analysts monitored by Fiscal.ai project Aehr’s yearly revenue will expand from $49.8 million in 2026 to $85.1 million in 2027.
Broader market activity remained subdued on Thursday. The Nasdaq rose 0.4% while the S&P 500 increased 0.2%. Industry competitors including Teradyne and FormFactor released no similar announcements, clearly indicating that AEHR’s advance stemmed exclusively from its order news.
Quarterly Results Approaching
The announcement’s timing carries additional significance. Aehr plans to publish its fiscal 2026 fourth-quarter and full-year financial results on July 14 — merely five days from Thursday’s disclosure.
This close timing likely motivated investors to act swiftly. A verified production contract from a strategic customer, revealed just before earnings, typically serves as an encouraging indicator entering the financial report.
Aehr specializes in test and burn-in equipment for semiconductor applications spanning power devices, sensors, memory products, processors, and silicon photonics elements. Its FOX-XP system has emerged as the primary revenue catalyst during the ongoing AI infrastructure expansion.
According to the company, its customer is advancing technology designed to enhance data transmission rates while reducing energy consumption in AI computing platforms and high-performance computing environments.
As of Thursday morning, AEHR shares had appreciated over 13% intraday, with both the third FOX-XP contract of 2026 and the upcoming fiscal year earnings announcement on July 14 now capturing investor attention.


